Viewing Study NCT03445858

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2026-01-13 @ 7:47 AM
Study NCT ID: NCT03445858
Status: COMPLETED
Last Update Posted: 2024-07-10
First Post: 2018-02-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults
Sponsor: Children's Hospital Medical Center, Cincinnati
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Childhood Solid Tumor View
None Childhood Lymphoma View
None Relapsed Cancer View
None Refractory Cancer View
None Adult Solid Tumor View
None Adult Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pediatric View
None Immunotherapy View
None Radiation View
None Radiotherapy View
None PD-1 View
None Decitabine View
None DNMT View
None Epigenetic View
None Solid Tumor View
None Saroma View
None Lymphoma View
None Checkpoint View
None Abscopal View
None Cancer View
None Immune View
None SBRT View